PHOSPHO1 and obesity due to melanocortin 4 receptor deficiency: At the same time, it is also necessary to carefully evaluate the effect and mechanism of PHOSPHO1 inhibitors on energy metabolism to provide novel strategies for the prevention and treatment of chronic metabolic disorders that plague human beings in the era of the obesity pandemic.